MyBlueDotsFrenelle Pharma Officially Launches: CEO Missling Attends JPM 2025 Representing Frenelle’s Portfolio MyBlueDots8 months ago01 mins PLYMOUTH, Minn.–(BUSINESS WIRE)–Our proprietary technology enables precise, sustained delivery of medications, reducing dosing frequency while enhancing efficacy & patient compliance Go to Source Author: Post navigation Previous: AI can enhance cervical cancer detection with medical image recognitionNext: China Pharmaceutical Regulatory Affairs Training Course: How to Gain and Maintain a Successful Marketing Authorisation in the PRC, Including Hong Kong, Macau and Taiwan (ONLINE EVENT: April 8-9, 2025) – ResearchAndMarkets.com
AI can spot which patients need treatment to prevent vision loss in young adults MyBlueDots5 hours ago 0
Half of people stop taking popular weight-loss drug within a year, study finds MyBlueDots5 hours ago 0
Study shows smoking increases the risk of type 2 diabetes, regardless of its characteristics MyBlueDots5 hours ago 0
Links between diabetes and depression are similar across Europe, study of over-50s in 18 countries finds MyBlueDots5 hours ago 0